Michael Freeman

Stock Analyst at Raymond James

(0.04)
# 4,354
Out of 4,829 analysts
1
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Michael Freeman

Bausch Health Companies
Jul 10, 2024
Initiates: Market Perform
Price Target: $8
Current: $4.78
Upside: +67.36%